About 3 results found for searched term "AM404" (0.421 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M11426 | AM404 | Cannabinoid |
| N-(4-HYDROXYPHENYL)-ARACHIDONYLAMIDE | ||
| AM404 is an endocannabinoid reuptake inhibitor that can block anandamide transport with IC50 values in the low mole range. The isolated rat hepatic artery was constricted by norepinephrine and relaxed by AM404. PEC50 value was 7.4 (corresponding EC50 value was 0.04 µM). It has neuroprotective effects. | ||
| M25079 | Zeluvalimab | PD-1/PD-L1 |
| AMG-404 | ||
| Zeluvalimab (AMG-404) is a monoclonal antibody targeting the PD-1 receptor that can be used for the research of cancer. | ||
| M58515 | CDDO-TFEA | Keap1-Nrf2 |
| CDDO-Trifluoethyl amide; RTA 404; TP-500 | ||
| CDDO-TFEA (RTA 404; TP-500) is a trifluoroacetamide derivative of CDDO with enhanced ability to cross the blood-brain barrier. CDDO is an Nrf2 activator that inhibits proliferation and induces differentiation and apoptosis in various cancer cells. CDDO-TFEA can enhance Nrf2 expression and signaling in various neurodegenerative disease models. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
